peptides for obesity research
Showing the single result
Peptides are short chains of amino acids that play important roles in many biological processes. In recent years, peptides have been investigated as potential treatments for obesity. Several peptides have been shown to reduce body fat in animal studies, and a few have entered clinical trials in humans.
One promising peptide is called obestatin. Obestatin was originally discovered as a hunger-suppressing hormone secreted by the stomach. However, it has also been shown to reduce body fat in mice. In one study, mice that were fed obestatin gained less weight and body fat than mice that were not fed the hormone. Obestatin appears to work by increasing energy expenditure and preventing the development of new fat cells.
another peptide with anti-obesity activity is leptin. Leptin is a hormone that is produced by fat cells and plays a key role in regulating energy balance. When levels of leptin are high, it signals to the brain that the body has enough energy and does not need to eat. However, obese individuals often have high levels of leptin due to their large amount of body fat. This results in leptin resistance, which means that the brain does not receive the signal to stop eating. Peptides that mimic the action of leptin have been shown to reduce food intake and body weight in animal studies.
A third peptide with potential as an obesity treatment is ghrelin antagonists. Ghrelin is a hormone that increases appetite and promotes.